ROME (AP) — The chairman of Moderna says the company has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up their own production is the best way to increase the global supply.
Interview with The Associated PressNoubar Afeyan reiterated the Moderna promise not to enforce patent infringement against anyone else who made coronavirus vaccines during the pandemic.
“We didn’t have to do that,” Afeyan told the AP. ”We think that was the right, responsible thing to do.” He added: “We want that to be helping the world.”
Moderna has been urged by the United Nations Health Agency to share its vaccine formulation.
Afeyan stated that the company examined whether it would make more sense to share messenger RNA technology. It determined that it could increase production and deliver billions more doses by 2022.
Afeyan added that they spent $2.5 billion and 10 years developing the platform that makes Moderna’s COVID-19 vaccine.
“Others joined the hunt when COVID-19 came along, and we’re glad to see that the capacity, therefore, has been increased considerably beyond what Moderna would have been able to do by itself,” Afeyan told the AP.